Chapter 15: Acute Respiratory Failure
Welcome to Last Minute Lecture.
This free chapter overview is designed to help students review and understand key concepts.
These summaries supplement not replaced the original textbook and may not be redistributed or resold.
For complete coverage, always consult the official text.
Imagine walking into the intensive care unit for the very first time.
Like the monitors are alarming, your patient's oxygen saturation is just steadily dropping, and you literally have seconds to figure out why.
Yeah, it is, I mean, it can feel incredibly overwhelming when you're suddenly faced with all that.
Right.
Well, welcome to the deep dive.
Today we are speaking directly to you, the college nursing student who is prepping to step up to that exact bedside.
Absolutely.
We are so glad you're here.
So we've got chapter 15 of Introduction to Critical Care Nursing right here on the table.
Acute respiratory failure.
And we're basically going to treat this as a focused one -on -one clinical prep session to get you ready for those critical moments.
Because honestly, all those alarms, the ventilator wave forms, the arterial blood gas values, it looks like a foreign language at first.
But our goal today is to show you the profound logic behind all of it.
The why behind what?
Exactly.
We're going to break down normal physiology, wash exactly how it cascades into instability, and then translate that into what you will physically see in your patient.
And most importantly, turn that into life -saving clinical judgments.
Once you understand that logic, critical care really just clicks into place.
So let's just jump right in by defining the problem.
Let's do it.
Chapter 15 hits us with a pretty major paradigm shift right out of the gate.
Acute respiratory failure, or ARF, is not actually a disease.
It's really not.
It is a condition.
I mean, it's the ultimate consequence of something else in the body going catastrophically wrong.
Fundamentally, ARF is simply the respiratory system's inability to provide oxygenation or to remove carbon dioxide.
That's it.
And because of that, we categorize it into two distinct types,
type 1 and type 2.
Okay, let's unpack those because that's huge.
So type 1 is oxygenation failure.
That's when the partial pressure of arterial oxygen, your PaO2, drops below 60 millimeters of mercury, but your carbon dioxide levels remain relatively normal.
Right, exactly.
And then type 2 is ventilation failure, where your PaO2, the carbon dioxide, rises above 45 millimeters of mercury, which ends up turning the blood acidic.
You got it.
So is it fair to say type 1 is essentially a supply chain issue?
Like the oxygen just isn't getting into the blood, while type 2 is more of a garbage disposal issue where the carbon dioxide just isn't being cleared out?
That is a great initial way to conceptualize it, yeah.
The supply chain is broken or the disposal system is backed up.
And what makes the ICU environment so incredibly challenging is a concept called acute on -chronic respiratory failure.
Acute on -chronic.
Right.
Yeah.
Imagine a patient who already has a chronically compromised system, say, severe COPD.
Their body has spent years adjusting to a faulty disposal system.
They're used to it.
Exactly.
But then a new stressor hits, like a mild respiratory infection.
That chronically strained system is suddenly just overwhelmed.
Their physiological compensations fail and they crash rapidly.
Wow.
Okay.
Let's look at the mechanics of how that crash actually happens.
For type 1, the supply chain failure, the text lists five main mechanisms of hypoxemia.
Right.
There's a few of them.
Yeah.
It's hypoventilation, intrapulmonary shunting,
ventilation perfusion mismatching, which we usually just call VQ mismatch diffusion defects, and finally low cardiac output or low hemoglobin.
But I want to pause on two of those because they constantly trip people up in clinicals.
What is the actual physical difference between a shunt and a VQ mismatch?
It's such a crucial distinction.
Let's use an analogy for this.
Okay.
I love a good analogy.
If the alveolus is a train station,
is a shunt like a train bypassing the station entirely, so no passengers meeting the oxygen cam board, whereas a VQ mismatch is like the train arriving, but the station is blocked by something.
Yes.
That analogy perfectly illustrates the physical pathology.
In a true pathologic shunt, blood returns to the left side of the heart without ever participating in gas exchange.
The train completely bypass the station.
Exactly.
You see this when alveoli totally collapse or fill with fluid, like in severe pneumonia or pulmonary edema.
And here is why this matters at the bedside.
Okay.
Why?
Because the blood never even saw the alveolus.
Turning up the patient's supplemental oxygen to 100 % will not fix the hypoxemia.
You literally cannot give oxygen to blood that isn't passing by.
Oh, wow.
That makes total sense.
Right.
You have to physically open those alveoli back up with pressure.
Oxygen alone won't do it.
Okay.
So then what about the VQ mismatch?
So a VQ mismatch is an imbalance.
Ventilation, the V, and perfusion, the QOR, just out of sync.
The train arrives, but the tracks are blocked.
Maybe a blood clot is stopping the perfusion or partial fluid is limiting the ventilation.
But oxygen might actually help there.
Yes, oxygen might help here because some gas exchange is still happening.
It's just highly inefficient.
Got it.
And what about the type 2 failure, you know, the ventilation failure where CO2 builds up?
That one is primarily driven by hypoventilation and something called increased dead space.
Dead space.
Yeah.
And dead space is the exact opposite of a shunt.
It's an area of the lung that is perfectly well ventilated, but it receives zero blood flow.
So the oxygen is just sitting there.
Sitting right there in the alveoli.
But there's no blood arriving to pick it up, and more importantly, no blood arriving to drop off its carbon dioxide.
So CO2 just accumulates in the bloodstream.
That sounds dangerous.
It is.
And this is vital to understand for your assessments.
Hypercapnia high CO2 is a powerful vasodilator in the brain.
It drastically increases cerebral blood flow.
Wait, so if hypercapnia is drastically increasing blood flow to the brain, that must be the very first thing you notice when you walk into the patient's room, right?
Yeah.
Like they aren't necessarily gasping for air first.
They're acting neurologically impaired.
Exactly.
The brain is incredibly sensitive to these changes.
Way before their oxygen drops to a critical level, the altered cerebral blood flow causes neurological symptoms.
You will see anxiety, restlessness,
confusion.
That is such a huge clinical pearl.
It really is.
And simultaneously, the body's initial compensatory mechanisms kick in.
You'll see tachycardia pumping blood faster to deliver whatever oxygen is left, and tachypnea hyperventilating to try and blow off that accumulating CO2.
But if you don't fix the underlying issue, you get those late ominous signs, right?
Right.
The patient becomes lethargic, then severely somnolent, and then, and this is the scary part, the breathing slows down.
Yes.
Bradypnea is a terrifying sign in a patient with respiratory failure.
It doesn't mean they are relaxing.
It means their respiratory muscles are completely exhausted and have just given up.
I want to highlight a crucial lifespan consideration the textbook brings up right here.
If you are assessing an older adult, you might completely miss those early warning signs we just talked about.
Oh, it is a massive safety trap.
In older adults, typical compensatory signs can be totally masked.
Their natural ventilatory response to hypoxia is naturally blunted just due to age -related changes in the central nervous system.
Medications play a role too, right?
Huge role.
They might be on a beta blocker for hypertension or a heart condition, which physically prevents their heart rate from rising, so you absolutely cannot rely on a racing pulse to warn you that an elderly patient is suffocating.
You have to look at the whole clinical picture.
Let's ground this in reality with the textbook's case study of Mr.
R.
Perfect.
So he's a 66 -year -old with a 60 -pack year smoking history who comes in with a COPD exacerbation.
We get two sets of arterial blood gases, or ABGs, for him.
Okay, let's hear the numbers.
His baseline from a clinic visit two weeks ago shows a pH of 7 .36, a Pan A2 of 55, and a PO2 of 69.
And his bicarbonate is 30.
Break those numbers down for us.
Okay, so that baseline is a textbook example of fully compensated respiratory acidosis.
Because of his COPD, his CO2 as high as 55 is well above the normal range of 35 to 45.
But look at his pH, 7 .36.
It's on the acidic side of normal, but it is still within the normal range.
How does that happen?
Because over months and years, his kidneys have held on to bicarbonate, which acts as a base.
We see his bicarb is elevated at 30 to buffer the acid.
This is his normal state.
He lives with high CO2, and his body has adapted.
But now, he's in the ICU on two liters of oxygen.
His new ABG shows his pH has dropped to 7 .32.
His Pans A2 has spiked to 64.
His PO2 dropped to 50.
So what is actually happening inside his body right now?
His physiological adaptations have entirely failed.
His pH of 7 .32 means he is now uncompensated and actively acidotic.
And his CO2 is climbing.
Rapidly climbing to 64, and his oxygen is dangerously low at 50.
This is the acute on -chronic failure we talked about earlier.
The infection or whatever trigger brought him in has overwhelmed his system, and he is actively deteriorating.
Okay, so the compensatory mechanisms have failed.
What are you physically doing at the bedside to stop this?
What is the priority care plan?
Your goals are immediate.
Maintain a patent airway, optimize oxygen delivery, and minimize oxygen demand.
Let's start with the airway.
For the airway, we might start with a non -invasive positive pressure ventilation, like a BiPAP mask, which pushes air in to keep those airways stented open.
But if he tires out, it means intubation and a mechanical ventilator.
And optimizing delivery.
That obviously means supplemental oxygen, but it also means ensuring his hemoglobin and cardiac output are sufficient.
You need the red blood cells to actually carry the oxygen to the tissues.
It's a whole system effort.
And what about minimizing demand?
That is pure aggressive nursing care.
You treat their fever, you manage their pain, and you reduce their agitation.
Because they're burning oxygen.
Exactly.
A patient thrashing around in bed is burning through massive amounts of oxygen.
You have to calm their system down so the oxygen they do have goes straight to their vital organs.
There is a brilliant clinical alert in the text about patient positioning during this phase.
It simply says, place the good lung down.
Why does that matter so much?
It's all about gravity and perfusion.
Blood flow naturally pools in the dependent or lower parts of the lungs just due to gravity.
If a patient has severe pneumonia in their right lung and you lay them on their right side, you are sending the bulk of their blood flow to the sick lung where gas exchange is terrible.
You're creating a massive VQ mismatch.
Just by rolling them over?
Yes.
But if you turn them onto their left side, the good lung, down gravity, pulls the blood flow to the healthy alveoli, instantly maximizing their gas exchange without changing a single setting on the ventilator.
That is such an elegant physical intervention.
Just using gravity.
What happens when both lungs are the bad lung?
This brings us to the most severe form of ARF, acute respiratory distress syndrome, or ARDS.
Yeah, ARDS is a whole different beast.
It is an extreme diffuse inflammatory meltdown of the lungs.
There's a specific definition for it, right?
Right.
The Berlin definition categorizes its severity based on the PIO2 ratio, basically comparing the oxygen in their blood to the fraction of oxygen they are inhaling.
And it happens in phases.
Three phases.
It starts with the acute exudative phase.
A massive clinical insult like severe sepsis or massive trauma triggers an uncontrolled systemic inflammatory response.
Inflammatory mediators flood the lungs, causing the pulmonary capillaries to become incredibly leaky.
So fluid just pours in.
Fluid, protein, blood cells, they pour straight into the alveoli.
The lungs become heavy, stiff, and waterlogged, and surfactant production just stops, meaning the alveoli collapse entirely.
And the clinical hallmark you see on assessment is refractory hypoxemia.
Just like you mentioned earlier with the train bypassing the station, you can turn the oxygen dial all the way up to 100 % and their blood oxygen barely moves.
It won't budge.
And the chest x -ray goes from looking mostly clear to a complete opaque whiteout.
Which brings us to the case study of Mrs.
P.
She is a trauma patient who develops ARDS.
She requires intubation, and the text breaks down her specific ventilator strategies.
Which are very different from normal ventilation.
Very different.
With ARDS, the lungs are so stiff and non -compliant that normal deep breaths from a ventilator will over -distend and literally tear the healthy alveoli that are left.
This is called shearing trauma.
So what do we do instead?
The standard of care is lung protective ventilation using very low tidal volumes, usually around 6 milliliters per kilogram of their predicted body weight.
We give them small, shallow breaths.
And to keep those fluid -filled alveoli from collapsing after every small breath, the text emphasizes high PEEP positive end -expertory pressure.
Yes.
PEEP is crucial.
It leaves a continuous column of pressure in the lungs at the end of exhalation.
It physically forces those fluid -filled, unstable alveoli to stay open, stenting them, which recruits them back into the gas exchange process.
But there are risks with that, right?
You have to monitor it closely.
High PEEP increases pressure in the chest, which can squeeze the vena cava and decrease venous blood return to the heart.
That can dangerously drop the patient's blood pressure.
It can also pop an alveolus and cause pneumothorax.
I want to push back on one of the interventions from Mrs.
P because it sounds honestly wild.
She is sedated, paralyzed with neuromuscular blockers, and still dying of hypoxia.
So the team flips her onto her stomach, prone positioning.
Yeah, proning.
Flipping a critically unstable patient prone when they have a breathing tube in their throat sounds incredibly dangerous.
Why take that risk?
Because it alters the V -Q ratio in a way nothing else can.
When a patient lies supine on their back, the heavy, fluid -filled front of the lungs squishes the back of the lungs.
The heart also rests on the lungs.
Which causes collapse.
Right, massive atelectasis or collapse in the posterior regions.
By proning the patient, turning them face down, you shift the blood flow to the healthier anterior portions of the lungs.
And more importantly, you relieve the physical pressure on those posterior alveoli, allowing them to open back up and exchange gas.
But the nursing care required for that must be staggering.
It is an incredibly risky, labor -intensive procedure.
It takes a whole team just to turn them safely.
As the nurse, you have to protect the airway from dislodging, apply moisture barriers to the face to handle the massive pooling of oral secretions.
Because they're face down.
Exactly.
And you literally have to tape their eyes shut with lubrication to prevent corneal ulcerations from the intense facial edema that develops from lying prone.
Unbelievable.
Let's shift from acute lung injury to chronic airflow limitations.
COPD and asthma.
I want to pause on the COPD oxygen guidelines.
We talked about Mr.
R earlier.
You're telling me that if a COPD patient is suffocating in front of me, giving them 100 % oxygen might actually kill them.
I know.
That feels entirely counterintuitive.
How does that work?
It is the ultimate critical care tightrope walk.
Many COPD patients live with chronic hypercapnia high CO2.
Over decades, their central nervous system stops using high CO2 as the primary trigger to breathe.
So what triggers it?
Their brain shifts to relying on low oxygen to stimulate breathing.
This is their hypoxic drive.
If you flood a COPD patient with 100 % oxygen during an exacerbation, their brain senses all that oxygen, assumes everything is fine, and blunts that hypoxic drive.
So they just stop breathing?
They can stop breathing entirely, causing their CO2 to rise to lethal coma -inducing levels.
So what is the protocol then?
The guideline dictates titrating oxygen very slowly, using a strict target saturation of 88 % to 92 % for those at risk of hypercapnia.
You give them just enough oxygen to survive, but not enough to shut off their drive to breathe.
And monitor closely.
You must reevaluate their ABGs every 30 to 60 minutes to ensure their CO2 isn't climbing.
Table 15 -2 gives us the pharmacology arsenal for this.
Albuterol, anticholinergics, systemic corticosteroids, and antibiotics.
Walk us through the mechanism of why we give these in this specific combination.
Sure.
So we give short -acting beta agonists like albuterol first, because they rapidly stimulate receptors that force the airway's smooth muscle to relax, but you must follow it with an anticholinergic.
Why is that?
Because the parasympathetic nervous system wants to constrict those airways right back down,
anticholinergics block that rest -and -digest clamping response.
Okay, that makes sense.
And the steroids?
Then we use systemic corticosteroids, like prednisone, for five days to shut down the massive inflammatory cascade causing all the swelling.
Finally, antibiotics are given because a bacterial respiratory infection is actually the most common trigger that throws a COPD patient into an exacerbation in the first place.
Now contrast that with an asthma exacerbation.
Asthma is also an inflammatory airway limitation, but it's largely reversible, right?
Yes.
It's an episodic hyperresponsiveness where the airways clap down, swell, and fill with thick mucus plugs.
The clinical alert box for asthma has one of the scariest phrases in critical care.
The silent chest.
It is terrifying.
If you are assessing an asthma patient and you hear loud, violent wheezing, they are in distress, but air is still moving.
If you are at the bedside and that wheezing suddenly stops, the chest goes completely silent and their oxygen hasn't improved.
That does not mean the medication worked.
Oh no.
No.
It means the airways have clamped completely shut.
Airflow has ceased.
This is impending respiratory arrest.
If standard meds fail there, the text notes advanced therapies like Heliox.
This is a mixture of helium and oxygen.
And the physics here are brilliant because helium is significantly less dense than oxygen.
It reduces the resistance of gas flow, allowing the oxygen to physically slip through those tiny, severely constricted airways.
Exactly.
It doesn't cure the asthma, but it buys you crucial time for the steroids to actually work.
So we've talked about treating failure, but what about threats we accidentally introduce?
Let's talk about infection.
Specifically, pneumonia and ventilator -associated events, or VAE.
How does putting a breathing tube in cause pneumonia?
Well, the human airway has brilliant natural defenses, warming the air, filtering out particles, the sneeze reflex, and the mucociliary escalator that sweeps debris up and out.
And the tube bypasses all of that.
An endotracheal tube bypasses every single one of them.
More importantly, it physically holds the glottis, the vocal cords, open.
This allows oral and gastric secretions, which quickly become colonized with hospital bacteria, to pool right above the cuff of the breathing tube.
And then they just leak down.
Eventually, those infected secretions seep down past the cuff and straight into the sterile lower lungs.
The CDC has an algorithm for tracking this.
It used to be called ventilator -associated pneumonia, or VAP, but the diagnosis was apparently too subjective.
Right.
Listening to a patient's lungs and hearing some crackles or looking at a blurry portable x -ray just wasn't objective enough for accurate data.
So the CDC shifted to VAE surveillance criteria, which is entirely objective.
A computer can literally track it.
What are the criteria?
Here's what you look for.
First, the patient is stable on the ventilator.
Then they have worsening oxygenation.
Think about what that means at the bedside.
Your patient was stable on a PEEP of 5.
Now they need a PEEP of 8.
Or you have to turn up their FiO2 by 20 % just to keep their oxygen steady for at least two days.
So that subtle change on the monitor is your first warning bell that an infection is brewing.
Precisely.
Then, you look for systemic signs of infection.
A temperature spike, an abnormal white blood cell count, and the doctor initiating a new antimicrobial agent.
If they meet those strict numbers, it's a VAE.
To prevent this, the Institute for Healthcare Improvement created a ventilator bundle.
These are specific nursing actions.
Explain the why behind them.
For instance, why do we elevate the head of the bed 30 to 45 degrees?
And why give a patient peptic ulcer medicine to prevent a lung infection?
We elevate the head of the bed to use gravity against aspiration.
It stops stomach contents from passively creeping up the esophagus.
And we give peptic ulcer prophylaxis because the intense physiological stress of the ICU causes stomach ulcers.
And if those bleed?
If those bleed, or if that highly acidic, bacteria -rich fluid refluxes up the esophagus, it slides right past that breathing tube and destroys the lung tissue.
We also do sedation vacations, waking the patient up daily to see if they are strong enough to pull the tube out.
Because honestly, getting the tube out is the ultimate prevention.
And we absolutely cannot ignore Box 15 -6,
the oral care protocol.
This is entirely nursing -driven.
Brushing the teeth twice a day, and specifically using 0 .12 % chlorhexidine swabs, twice daily.
Yes, that chemical disinfection of the mouth drastically cuts down the bacterial load that could seep into the lungs.
Moving from the airways to the blood vessels, let's look at vascular failure, the pulmonary embolism.
Okay, yeah.
So, what happens when the ventilation is perfect but the blood flow just suddenly stops?
This is a classic severe VQ mismatch caused by a clot, usually migrating from a deep vein thrombosis in the leg.
It's driven by Vircho's triad, venous stasis, so blood sitting still, hypercoagulability of the blood, and vessel wall damage.
When it breaks off.
When that clot breaks off and lodges in the pulmonary artery, it creates massive dead space.
The lungs are expanding, the oxygen is right there, but absolutely no blood is passing through to pick it up.
That is terrifying.
It is.
This blockage causes massive pulmonary hypertension, and the right ventricle of the heart can actually from trying to pump against that setter wall of resistance.
How do we quickly prove it's a PE?
The text mentions a D -dimer test.
A D -dimer measures fibrin degradation.
Essentially, it detects the body trying to break down a clot anywhere in the system.
It is highly sensitive, meaning if it's negative, you can be quite confident they don't have a PE.
But if it's positive?
It is terribly nonspecific.
A recent surgery, a pregnancy, or a severe infection can all elevate a D -dimer, so it's not enough to diagnose.
The gold standard diagnosis is the MD -CTA, the multi -detector computed tomography angiography or spiral CT.
It provides direct 3D visualization of the actual clot blocking the pulmonary arteries.
Once we find the clot, we treat it with anticoagulants, usually starting with a heparin drip.
But there's a huge trap door here, HIT, heparin -induced thrombocytopenia.
Wait, heparin is supposed to stop clots?
So how does it cause a condition where platelets drop and microclots form?
It's a terrifying paradoxical immune reaction.
You give a patient heparin to stop their clotting cascade, but in some patients, their body creates antibodies that bind to the heparin and actually activate their platelets en masse.
Activating them.
Oh, wow.
Yeah.
This causes microclots to form all over the body.
And because all the platelets are being used up to make these microclots, their overall platelet count on their lab work plummets.
So what do you do?
As a nurse, if you see a patient on heparin whose platelet count suddenly drops by 50 % or they start developing new clots, you must suspect HIT.
You stop all heparin products immediately, even flushing IVs with it, and switch to a direct thrombin inhibitor like argotrobin.
That brings us to our final specific condition.
This is one that used to be strictly a pediatric issue, but thanks to massive medical advancements, it is now a critical care issue for adults.
Cystic fibrosis.
Right.
Cystic fibrosis is an autosomal recessive genetic disorder.
The underlying pathology is a physical defect in the CFTR gene, which controls the chloride ion channels in the epithelial cells.
And what does that actually do?
Well, because chloride can't move properly out of the cells, water doesn't follow it.
The result is thick, incredibly sticky, dehydrated mucus all over the body.
In the lungs, this concrete -like mucus blocks the airways and creates a perfect, protected breeding ground for bacteria, particularly pseudomonas derigenosa.
If an adult CF patient ends up in the ICU in acute respiratory failure,
the text highlights three cornerstones of care.
First, heavy -duty antibiotic eradication therapy targeting that pseudomonas.
Second, aggressive airway clearance.
We use a nebulized drug called pulmozyme for that.
Right, which is recombinant human DNAs.
It literally chops up the DNA strands of the dead white blood cells trapped in the mucus to make it thinner and easier to cough up, often paired with 7 % hypertonic saline to draw water back into the airways via osmosis.
It's amazing.
And third, aggressive nutritional support, because these patients burn massive amounts of calories just trying to force air through those blocked passages.
What is truly fascinating here is how the landscape of CF is fundamentally changing, which brings us to a much broader implication for critical care nursing as a whole.
We've covered a massive amount of textbook material today.
But before we let you go, let's tie this all directly back to you, the student.
From tracking a COPD patient's oxygen saturation so you don't accidentally blunt their hypoxic drive to meticulously swabbing an intubated patient's mouth with chlorhexidine to prevent a VAE to catching a sudden drop in platelets on a heparin drip you, the nurse at the bedside, are the final line of defense against physiological failure.
That's right.
The monitors just beep.
You're the one who has to interpret the mechanism of failure and intervene.
Any final thoughts to leave them with?
Actually, here is a final thought for you to carry into your clinical rotations.
In the genetics box of this chapter, the text mentions a relatively new drug called ivacaftor.
Oh, yeah.
Unlike every other treatment we discussed today, the ventilators, the positioning, the which just manage the downstream symptoms of failure, ivacaftor binds directly to the defective chloride channels and specific CF mutations and physically forces the gate open.
It treats the DNA level defect.
Think about what that means for your career.
As you enter the ICU today, you are stepping into an era where critical care nursing is evolving from managing generalized systemic failure to delivering precision, genetic level medicine right at the bedside.
So the next time you look at a patient's charting or stare at a frighteningly low oxygen saturation, remember the physiological logic is there, waiting for you to find it.
Good luck on your exams and good luck in your clinical rotations.
From all of us on the Last Minute Lecture Team, thank you for letting us be a part of your journey.
Keep diving deep.
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.
Support LML ♥Related Chapters
- Acute Respiratory Failure & ARDSLewis's Medical-Surgical Nursing: Assessment and Management of Clinical Problems
- Alterations of Pulmonary FunctionUnderstanding Pathophysiology
- Critical Care of Patients With Respiratory EmergenciesMedical-Surgical Nursing: Concepts for Interprofessional Collaborative Care
- Management of Patients with Chest and Lower Respiratory Tract DisordersBrunner & Suddarth’s Textbook of Medical-Surgical Nursing
- Alterations of Pulmonary FunctionPathophysiology: The Biologic Basis for Disease in Adults and Children
- Care of Patients With Disorders of the Lower Respiratory SystemMedical-Surgical Nursing: Concepts and Practice